Skip to main content

Table 2 Characteristics of study participants

From: Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012

Characteristics

Entire sample, n (%)

Dead, n (%)

HIV+

(N = 13729)

HIV-

(N = 510313)

p-value

HIV+

(N = 3401)

HIV-

(N = 47647)

p-value

Age at study entry, median (Q1, Q3) years

38 (32, 46)

36 (24, 50)

<0.001

41 (34, 49)

71 (59, 78)

<0.001

Age at death, median (Q1, Q3) years

   

46 (39, 55)

80 (69, 87)

<0.001

Sex

 Male

11017 (80.25)

256440 (50.25)

<0.001

2716 (79.86)

24394 (51.20)

<0.001

 Female

2712 (19.75)

253873 (49.75)

685 (20.14)

23253 (48.80)

Follow-up time, median (Q1, Q3) years

7.22 (2.96, 12.97)

12.70 (4.76,16.75)

<0.001

3.91 (1.16, 7.60)

8.42 (4.25, 12.58)

<0.001

Antiretroviral therapy ever?

 Yes

10165 (74.04)

  

2377 (69.89)

  

 No

3564 (25.96)

--

 

1024 (30.11)

--

 
  1. Legend: Q1, 25th percentile; Q3, 75th percentile